Opioid receptors of human placental villi modulate acetylcholine release

Mahmoud Ahmed, Mark A. Horst

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The human placental villous tissue contains components of the cholinergic system and opioid receptors of the kappa type. In vitro stimulation of the villous tissue releases acetylcholine in organ baths. A selective kappa agonist, ethylketocyclazocine, inhibits the release of acetylcholine. This inhibition is reversed by the antagonist Mr 2266. The antagonist alone stimulates the release of acetylcholine 18-fold over control. These results demonstrate an interaction between the placental opioid receptors and the cholinergic system in a non-neural tissue. The modulation of acetylcholine release by endogenous opioid peptides could be one of the in vivo functions of placental opioid receptors.

Original languageEnglish (US)
Pages (from-to)535-540
Number of pages6
JournalLife Sciences
Volume39
Issue number6
DOIs
StatePublished - Aug 11 1986
Externally publishedYes

Fingerprint

Chorionic Villi
Opioid Receptors
Acetylcholine
Tissue
Cholinergic Agents
Ethylketocyclazocine
kappa Opioid Receptor
Opioid Peptides
Cholinergic Receptors
Baths
Modulation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Opioid receptors of human placental villi modulate acetylcholine release. / Ahmed, Mahmoud; Horst, Mark A.

In: Life Sciences, Vol. 39, No. 6, 11.08.1986, p. 535-540.

Research output: Contribution to journalArticle

@article{1f4f6bbf5d6144ab881a59b0e232cf9c,
title = "Opioid receptors of human placental villi modulate acetylcholine release",
abstract = "The human placental villous tissue contains components of the cholinergic system and opioid receptors of the kappa type. In vitro stimulation of the villous tissue releases acetylcholine in organ baths. A selective kappa agonist, ethylketocyclazocine, inhibits the release of acetylcholine. This inhibition is reversed by the antagonist Mr 2266. The antagonist alone stimulates the release of acetylcholine 18-fold over control. These results demonstrate an interaction between the placental opioid receptors and the cholinergic system in a non-neural tissue. The modulation of acetylcholine release by endogenous opioid peptides could be one of the in vivo functions of placental opioid receptors.",
author = "Mahmoud Ahmed and Horst, {Mark A.}",
year = "1986",
month = "8",
day = "11",
doi = "10.1016/0024-3205(86)90510-2",
language = "English (US)",
volume = "39",
pages = "535--540",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Opioid receptors of human placental villi modulate acetylcholine release

AU - Ahmed, Mahmoud

AU - Horst, Mark A.

PY - 1986/8/11

Y1 - 1986/8/11

N2 - The human placental villous tissue contains components of the cholinergic system and opioid receptors of the kappa type. In vitro stimulation of the villous tissue releases acetylcholine in organ baths. A selective kappa agonist, ethylketocyclazocine, inhibits the release of acetylcholine. This inhibition is reversed by the antagonist Mr 2266. The antagonist alone stimulates the release of acetylcholine 18-fold over control. These results demonstrate an interaction between the placental opioid receptors and the cholinergic system in a non-neural tissue. The modulation of acetylcholine release by endogenous opioid peptides could be one of the in vivo functions of placental opioid receptors.

AB - The human placental villous tissue contains components of the cholinergic system and opioid receptors of the kappa type. In vitro stimulation of the villous tissue releases acetylcholine in organ baths. A selective kappa agonist, ethylketocyclazocine, inhibits the release of acetylcholine. This inhibition is reversed by the antagonist Mr 2266. The antagonist alone stimulates the release of acetylcholine 18-fold over control. These results demonstrate an interaction between the placental opioid receptors and the cholinergic system in a non-neural tissue. The modulation of acetylcholine release by endogenous opioid peptides could be one of the in vivo functions of placental opioid receptors.

UR - http://www.scopus.com/inward/record.url?scp=0022483045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022483045&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(86)90510-2

DO - 10.1016/0024-3205(86)90510-2

M3 - Article

VL - 39

SP - 535

EP - 540

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 6

ER -